Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company's lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich’s ataxia.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.